<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WFXIHJLN</identifier><date>2012</date><creator>Šeruga, Boštjan</creator><relation>documents/doc/W/URN_NBN_SI_doc-WFXIHJLN_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WFXIHJLN_001.txt</relation><format format_type="issue">1</format><format format_type="volume">16</format><format format_type="type">article</format><format format_type="extent">str. 27-28, 57</format><identifier identifier_type="COBISSID">1318779</identifier><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WFXIHJLN</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Clinical trials, phase III</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Klinično preizkušanje novih vrst zdravljenja v onkologiji - zahtevajmo več!</title></Record>